ALNYLAM PHARMACEUTICALS, INC. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

ALNYLAM PHARMACEUTICALS, INC. has filed 1,657 SEC EDGAR filings since 09 Jul 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page

25

Current page

33

8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 02 Nov 2016
Reporting date: 02 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Oct 2016
Reporting date: 13 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Oct 2016
Reporting date: 12 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36407

8-K

Filing date: 05 Oct 2016
Reporting date: 05 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Sep 2016
Reporting date: 19 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 21 Sep 2016
Reporting date: 19 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36407

FORM 8-K

Filing date: 19 Sep 2016
Reporting date: 19 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36407

FORM 10-Q

Filing date: 04 Aug 2016
Reporting date: 30 Jun 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 04 Aug 2016
Reporting date: 04 Aug 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Jul 2016
Reporting date: 19 Jul 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36407

FORM 8-K

Filing date: 15 Jun 2016
Reporting date: 09 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jun 2016
Reporting date: 03 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-36407

CT ORDER filing

Filing date: 19 May 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36407

FORM 8-K

Filing date: 06 May 2016
Reporting date: 03 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36407

10-Q

Filing date: 04 May 2016
Reporting date: 31 Mar 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 02 May 2016
Reporting date: 29 Apr 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .